These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28112281)

  • 1. A measure of productivity and innovation in the pharmaceutical industry 2011-2015.
    Harrison R
    Drugs Today (Barc); 2016 Nov; 52(11):627-633. PubMed ID: 28112281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mergers and innovation in the pharmaceutical industry.
    Comanor WS; Scherer FM
    J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 2. Pharma's challenges and their commitment to innovation.
    Abou-Gharbia M; Childers WE
    J Med Chem; 2014 Jul; 57(13):5525-53. PubMed ID: 24428137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 1. Criticisms faced by the pharmaceutical industry.
    Abou-Gharbia M; Childers WE
    J Med Chem; 2013 Jul; 56(14):5659-72. PubMed ID: 23557017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open innovation in early drug discovery: roadmaps and roadblocks.
    Reichman M; Simpson PB
    Drug Discov Today; 2016 May; 21(5):779-88. PubMed ID: 26743597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery in pharmaceutical industry: productivity challenges and trends.
    Khanna I
    Drug Discov Today; 2012 Oct; 17(19-20):1088-102. PubMed ID: 22627006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessing external innovation in drug discovery and development.
    Tufféry P
    Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift.
    Sams-Dodd F
    Drug Discov Today; 2013 Mar; 18(5-6):211-7. PubMed ID: 23131208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional technology gap and innovation efficiency trap in Chinese pharmaceutical manufacturing industry.
    Lai H; Shi H; Zhou Y
    PLoS One; 2020; 15(5):e0233093. PubMed ID: 32433705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organizational effectiveness: a key to R&D productivity.
    Tollman P; Panier V; Dosik D; Biondi P; Cuss F
    Nat Rev Drug Discov; 2016 Jul; 15(7):441-2. PubMed ID: 27312725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the effectiveness and impact of an open innovation platform.
    Carroll GP; Srivastava S; Volini AS; Piñeiro-Núñez MM; Vetman T
    Drug Discov Today; 2017 May; 22(5):776-785. PubMed ID: 28137644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The productivity crisis in pharmaceutical R&D.
    Pammolli F; Magazzini L; Riccaboni M
    Nat Rev Drug Discov; 2011 Jun; 10(6):428-38. PubMed ID: 21629293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On strategic choices faced by large pharmaceutical laboratories and their effect on innovation risk under fuzzy conditions.
    Puente J; Gascon F; Ponte B; de la Fuente D
    Artif Intell Med; 2019 Sep; 100():101703. PubMed ID: 31607342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research on the influence of technological innovation on carbon productivity and countermeasures in China.
    Han B
    Environ Sci Pollut Res Int; 2021 Apr; 28(13):16880-16894. PubMed ID: 33392990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
    Janero DR
    Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American export control, technology spillover and innovation of Chinese pharmaceutical Industry.
    Hui J
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1151-1155. PubMed ID: 28671099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open innovation platforms to boost pharmaceutical collaborations: evaluating external compounds for desired biological activity.
    Nilsson N; Felding J
    Future Med Chem; 2015; 7(14):1853-9. PubMed ID: 26393392
    [No Abstract]   [Full Text] [Related]  

  • 19. How to improve R&D productivity: the pharmaceutical industry's grand challenge.
    Paul SM; Mytelka DS; Dunwiddie CT; Persinger CC; Munos BH; Lindborg SR; Schacht AL
    Nat Rev Drug Discov; 2010 Mar; 9(3):203-14. PubMed ID: 20168317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Open innovation for pharmaceutical industries].
    Matsumoto Y; Sakata T
    Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):199-204. PubMed ID: 23575425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.